|
|
| | (S,R,S)-AHPC-Me-C6-NH2 Basic information |
| Product Name: | (S,R,S)-AHPC-Me-C6-NH2 | | Synonyms: | (S,R,S)-AHPC-Me-C6-NH2;(2S,4R)-1-((S)-2-(7-aminoheptanamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-((S)-1-(4-(4-methylthiazol-5-yl)phenyl)ethyl)pyrrolidine-2-carboxamide;(2S,4R)-1-[(2S)-2-(7-aminoheptanamido)-3,3-dimethylbutanoyl]-4-hydroxy-N-[(1S)-1-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]ethyl]pyrrolidine-2-carboxamide | | CAS: | 2411422-49-4 | | MF: | C30H45N5O4S | | MW: | 571.78 | | EINECS: | | | Product Categories: | | | Mol File: | 2411422-49-4.mol |  |
| | (S,R,S)-AHPC-Me-C6-NH2 Chemical Properties |
| Boiling point | 831.1±65.0 °C(Predicted) | | density | 1.186±0.06 g/cm3(Predicted) | | pka | 13.97±0.40(Predicted) | | form | Solid | | color | Off-white to light yellow |
| | (S,R,S)-AHPC-Me-C6-NH2 Usage And Synthesis |
| Uses | (S,R,S)-AHPC-Me-C6-NH2 can be used for the synthesis of PROTAC[1]. (S,R,S)-AHPC-Me-C6-NH2 (Compound SI-9) contains VHL ligand 2 (HY-112078)[2]. | | References | [1] Haibing Zhou, et al. Oseltamivir PROTAC compound, preparation method thereof and application thereof in anti-influenza virus drugs. Patent CN112592331A.
[2] Bondeson DP, et al. Systematic profiling of conditional degron tag technologies for target validation studies. Nat Commun. 2022 Sep 20;13(1):5495. DOI:10.1038/s41467-022-33246-4 |
| | (S,R,S)-AHPC-Me-C6-NH2 Preparation Products And Raw materials |
|